Blog
Three Things to Know about FDA’s Newest Draft Guidance on Cell & Gene Therapies
On September 23, 2025, the FDA published three new draft guidances that give insight into a regulatory framework for cell and gene therapies (CGTs) that is now coming into focus. By releasing these guidances together, FDA is offering a blueprint for the future of CGT regulation….
By: MoFo Life Sciences